EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Multifocal Optics for Myopia Control

Christine Schmucker, Wolf Alexander Lagrèze

Klinische Monatsblätter für Augenheilkunde · 01.10.2024 · 241 (10) · 1129-1133

DOI: 10.1055/a-2397-1660 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.10.2024. Verfasst von Christine Schmucker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Evidence in Medicine, University of Freiburg, Germany. Hauptthemen laut MEDLINE: Eyeglasses, Myopia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approaches like undercorrection with single-vision lenses have proven ineffective. Recent research underscores the significance of peripheral vision in managing myopia progression. While hyperopic defocus in the peripheral retina may encourage axial elongation, multifocal lenses designed to induce peripheral myopic defocus can potentially curb this elongation. Randomized controlled trials (RCTs) have demonstrated that spectacle lenses with peripheral modifications, such as highly aspherical lenslets (HAL) or defocus incorporated multiple segments (DIMS), reduce myopia progression and axial elongation over 2 years. Similarly, multifocal contact lenses, especially those with high-add power (+ 2.50 D), have shown comparable reductions over 3 years. Safety is a critical consideration in myopia control. Multifocal spectacle lenses with peripheral plus designs are generally well tolerated, with only transient side effects, like dizziness and blurred vision. Soft multifocal contact lenses also exhibit a favorable safety profile, with low rates of serious adverse events. Thorough monitoring and reporting in these studies are essential to provide assurance about the safety of these interventions for children. Future research should aim to include more diverse populations in order to ensure the generalizability of findings across various demographic groups. Additionally, real-world data would offer valuable insights into the performance of these treatments in everyday scenarios. Observational studies, less influenced by industry sponsorship, could further validate these findings. Lastly, the clinical significance of the observed effects should be critically assessed to confirm that the reported benefits lead to meaningful reductions in myopia progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EyeglassesMyopiaHumansTreatment OutcomeChildEvidence-Based MedicineEquipment DesignAdolescentEquipment Failure Analysis

Autor:innen und Institutionen

  • Institute for Evidence in Medicine, University of Freiburg, Germany.
  • Neuro-/Pediatric Ophthalmology, University of Freiburg, Germany.

Zitieren

APA

Schmucker, C., & Lagrèze, W. A. (2024). Multifocal Optics for Myopia Control. Klinische Monatsblätter für Augenheilkunde, 241(10), 1129-1133. https://doi.org/10.1055/a-2397-1660

Vancouver

Schmucker C, Lagrèze WA. Multifocal Optics for Myopia Control. Klinische Monatsblätter für Augenheilkunde. 2024;241(10):1129-1133. doi:10.1055/a-2397-1660

BibTeX
@article{Schmucker2024,
  author = {Schmucker, Christine and Lagrèze, Wolf Alexander},
  title = {Multifocal Optics for Myopia Control},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2024},
  volume = {241},
  number = {10},
  pages = {1129--1133},
  doi = {10.1055/a-2397-1660}
}
Kostenlos starten →